2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

June 2013 | 241 pages | ID: 2E8CE55E8FCEN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

• Hospitals
• Commercial/Private Labs
• Blood Banks
• Physician Offices
• Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 241 pages and 14 tables

Contents

I. INTRODUCTION

II . HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
    Classification
    Transmission of Infection
    Occupational Hazards
    Acute Hepatitis
    Diagnosis of Acute Infection
    Chronic Hepatitis
    HCV and Other Chronic Liver Diseases
    Alcoholic Liver Disease
    Hepatitis B Coinfection
    Cirrhosis and Hepatocellular Carcinoma
    Diagnostic Tests
    Possible Indications for HCV RNA Testing
    Conclusions and Future Direction
E. Hepatitis D
    Historical Perspective
    Epidemiology
    HBV-HDV "Coinfection" vs. "Superinfection"
    Methods of Detecting HDV
    Prevention
F. Hepatitis E
    Background
    Prevalence of the Disease
    Diagnostic Tests
    Epidemiologic Serosurveys
    Serologic Cross-Reactivity
G. Hepatitis G
    Vaccines and Drugs
H. Review of Leading Analyzers Marketed by: Abbott, Beckman

COULTER/DANAHER, BIOMERIEUX, ORTHO-CLINICAL DIAGNOSTICS, ROCHE, SIEMENS, TOSOH, WALLAC AND OTHER SUPPLIERS

I. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation